All In Biotech

Drug Trial Radar · NCT02229539

Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy

A Phase III Placebo-Controlled, Randomized Three-Arm Study of Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy

Last checked: Nov 19, 2026Latest source record: May 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 275 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

275

Actual

Start

Nov 18, 2014

Primary completion

May 23, 2016

Study completion Mar 15, 2019

Sponsor

Lead sponsor
Alliance for Clinical Trials in OncologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
Sep 1, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test whether a mouthwash made with a drug called doxepin can reduce the pain caused by mouth sores resulting from radiation therapy. A number of mouth rinse preparations exist for patients with treatment-related oral mucositis pain such as the DLA rinse, an over-the-counter medication. This study will evaluate the effects of doxepin compared to DLA (diphenhydramine, lidocaine and antacids) and placebo.Doxepin is approved by the Food and Drug Administration (FDA) for the treatment of depression, anxiety, long-term pain management, as well as management of rash.

Conditions

  • Acute Oral Mucositis Pain

Interventions

  • doxepin hydrochloride oral solutionDrug

    2.5 mL (25 mg) doxepin and 2.5 mL water administered orally

  • DLA (diphenhydramine, lidocaine and antacids) rinseDrug

    5.0 mL administered orally

  • PlaceboOther

    2.5 mL placebo and 2.5 mL water administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Area Under the Curve (AUC) of Total Pain ReductionTime frame: Baseline, 5, 15, 30, 60, 120, 240 minutes post treatment

Locations

350 sites in 1 country. Site status is shown where the registry gives one.

  • Anchorage Radiation Therapy Center

    Anchorage, Alaska

  • Alaska Breast Care and Surgery LLC

    Anchorage, Alaska

  • Alaska Oncology and Hematology LLC

    Anchorage, Alaska

  • Alaska Regional Hospital

    Anchorage, Alaska

  • Alaska Women's Cancer Care

    Anchorage, Alaska

  • Anchorage Oncology Centre

    Anchorage, Alaska

  • Katmai Oncology Group

    Anchorage, Alaska

  • Providence Alaska Medical Center

    Anchorage, Alaska

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California

  • Epic Care-Dublin

    Dublin, California

  • Bay Area Breast Surgeons Inc

    Emeryville, California

  • Epic Care Partners in Cancer Care

    Emeryville, California

  • Comprehensive Cancer Care and Research Institute of Colorado LLC

    Englewood, California

  • Contra Costa Regional Medical Center

    Martinez, California

  • Alta Bates Summit Medical Center - Summit Campus

    Oakland, California

  • Bay Area Tumor Institute CCOP

    Oakland, California

  • Hematology and Oncology Associates-Oakland

    Oakland, California

  • Rocky Mountain Cancer Centers-Aurora

    Aurora, Colorado

  • The Medical Center of Aurora

    Aurora, Colorado

  • Boulder Community Hospital

    Boulder, Colorado

  • Rocky Mountain Cancer Centers-Boulder

    Boulder, Colorado

  • Penrose-Saint Francis Healthcare

    Colorado Springs, Colorado

  • Rocky Mountain Cancer Centers-Penrose

    Colorado Springs, Colorado

  • Porter Adventist Hospital

    Denver, Colorado

  • Exempla Saint Joseph Hospital

    Denver, Colorado

  • Presbyterian - Saint Lukes Medical Center - Health One

    Denver, Colorado

  • Rocky Mountain Cancer Centers-Midtown

    Denver, Colorado

  • Rocky Mountain Cancer Centers-Rose

    Denver, Colorado

  • Rose Medical Center

    Denver, Colorado

  • Colorado Blood Cancer Institute

    Denver, Colorado

  • Mercy Medical Center

    Durango, Colorado

  • Southwest Oncology PC

    Durango, Colorado

  • Swedish Medical Center

    Englewood, Colorado

  • Mountain Blue Cancer Care Center

    Golden, Colorado

  • North Colorado Medical Center

    Greeley, Colorado

  • Rocky Mountain Cancer Centers-Greenwood Village

    Greenwood Village, Colorado

  • Rocky Mountain Cancer Centers-Lakewood

    Lakewood, Colorado

  • Saint Anthony Hospital

    Lakewood, Colorado

  • Rocky Mountain Cancer Centers-Littleton

    Littleton, Colorado

  • Littleton Adventist Hospital

    Littleton, Colorado

Showing 40 of 350 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.